Rein advanced the clinical development of its lead asset, LTI-03, and aims to initiate a Phase 2 trial for the treatment of idiopathic pulmonary f ...

Explore JANX's promising early data in prostate cancer immunotherapy. Understand market challenges, buyout rumors, and ...

Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have validated a test that can accurately predict which patients with prostate ...

LITTLE ROCK, Ark. — On Monday, April 7, a proposed bill that would appropriate $750 million for a controversial Franklin County prison failed on the Senate floor for a fourth time. Requiring a 3/4 ...

Distinguished, highly accomplished clinician with stellar track record of successfully leading numerous registrational trials through global regulatory approvals, and establishing new standards of ...

Appearance Medicine’s Vibe Shift: Here’s What You Need To Know About ‘Undetectable Aesthetics’ Forget over-filled, frozen ...

Fact checked by Nick Blackmer As women age, their bodies transform. Fat more easily settles in their midsection. They tend to ...

BioLife Solutions, Inc.  ("BioLife" or the "Company"), a leading developer and supplier of bioproduction products and services for the cell and gene therapy ("CGT") market, today announced the ...

Urothelium is the term for the mucous membrane that lines the urinary tract. This includes the renal pelvis, ureter, urinary ...

Pulmonary arterial hypertension (PAH) is a rare form of pulmonary hypertension. It occurs because progressive vascular ...

New compelling results demonstrate 18 months of both sustained reduction in immunoglobulin G antibodies and sustained improvement in gMG symptoms in pivotal Vivacity-MG3 study and open label extension ...

Tactile Systems' Flexitouch Plus boosts revenue, but competition, regulatory risks, and revenue misses raise caution. Read more about TCMD stock here.